CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome

被引：73

作者：

Kulkarni, Smita ^{[1
,2
,3
]}

Lied, Alexandra ^{[2
,3
]}

Kulkarni, Viraj ^{[2
,3
]}

Rucevic, Marijana ^{[2
,3
,4
]}

Martin, Maureen P. ^{[5
]}

Walker-Sperling, Victoria ^{[6
]}

Anderson, Stephen K. ^{[5
]}

Ewy, Rodger ^{[1
]}

Singh, Sukhvinder ^{[1
]}

Nguyen, Hoang ^{[1
]}

McLaren, Paul J. ^{[7
,8
]}

Viard, Mathias ^{[5
]}

Naranbhai, Vivek ^{[2
,3
]}

Zou, Chengcheng ^{[9
]}

Lin, Zhansong ^{[9
]}

Gatanaga, Hiroyuki ^{[9
,10
]}

Oka, Shinichi ^{[9
,10
]}

Takiguchi, Masafumi ^{[9
]}

Thio, Chloe L. ^{[11
]}

Margolick, Joseph ^{[12
]}

Kirk, Gregory D. ^{[13
]}

Goedert, James J. ^{[14
]}

Hoots, W. Keith ^{[15
]}

Deeks, Steven G. ^{[16
]}

Haas, David W. ^{[17
]}

Michael, Nelson ^{[18
]}

Walker, Bruce ^{[2
,3
,19
,20
]}

Le Gall, Sylvie ^{[2
,3
]}

Chowdhury, Fatema Z. ^{[2
,3
]}

Yu, Xu G. ^{[2
,3
]}

Carrington, Mary ^{[2
,3
,5
]}

机构：

[1] Texas Biomed Res Inst, San Antonio, TX 78227 USA

[2] MIT, Massachusetts Gen Hosp, Ragon Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA

[3] Harvard Univ, Cambridge, MA 02138 USA

[4] Olink Prote, Watertown, MA USA

[5] Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD 21701 USA

[6] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21701 USA

[7] Publ Hlth Agcy Canada, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada

[8] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada

[9] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan

[10] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan

[11] Johns Hopkins Univ, Dept Med, Baltimore, MD USA

[12] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA

[13] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA

[14] NCI, Epidemiol & Biostat Program, Div Canc Epidemiol & Genet, Rockville, MD USA

[15] NHLBI, Div Blood Dis & Resources, NIH, Bldg 10, Bethesda, MD 20892 USA

[16] San Francisco Gen Hosp, Med Ctr, San Francisco, CA 94110 USA

[17] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA

[18] Walter Reed Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA

[19] Howard Hughes Med Inst, Chevy Chase, MD USA

[20] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA

来源：

NATURE IMMUNOLOGY | 2019年 / 20卷 / 07期

关键词：

LONG NONCODING RNAS; HOST GENETIC-VARIATION; MESSENGER-RNA; VIRUS REPLICATION; EXPRESSION; INFECTION; PROGRESSION; CELLS; HEPATITIS; DENSITY;

D O I：

10.1038/s41590-019-0406-1

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Multiple genome-wide studies have identified associations between outcome of human immunodeficiency virus (HIV) infection and polymorphisms in and around the gene encoding the HIV co-receptor CCR5, but the functional basis for the strongest of these associations, rs1015164A/G, is unknown. We found that rs1015164 marks variation in an activating transcription factor 1 binding site that controls expression of the antisense long noncoding RNA (lncRNA) CCR5AS. Knockdown or enhancement of CCR5AS expression resulted in a corresponding change in CCR5 expression on CD4(+) Tcells. CCR5AS interfered with interactions between the RNA-binding protein Raly and the CCR5 3' untranslated region, protecting CCR5 messenger RNA from Raly-mediated degradation. Reduction in CCR5 expression through inhibition of CCR5AS diminished infection of CD4(+) Tcells with CCR5-tropic HIV in vitro. These data represent a rare determination of the functional importance of a genome-wide disease association where expression of a lncRNA affects HIV infection and disease progression.

引用

页码：824 / +

页数：13

共 50 条

[1] CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
Smita Kulkarni
Alexandra Lied
Viraj Kulkarni
Marijana Rucevic
Maureen P. Martin
Victoria Walker-Sperling
Stephen K. Anderson
Rodger Ewy
Sukhvinder Singh
Hoang Nguyen
Paul J. McLaren
Mathias Viard
Vivek Naranbhai
Chengcheng Zou
Zhansong Lin
Hiroyuki Gatanaga
Shinichi Oka
Masafumi Takiguchi
Chloe L. Thio
Joseph Margolick
Gregory D. Kirk
James J. Goedert
W. Keith Hoots
Steven G. Deeks
David W. Haas
Nelson Michael
Bruce Walker
Sylvie Le Gall
Fatema Z. Chowdhury
Xu G. Yu
Mary Carrington
Nature Immunology, 2019, 20 : 824 - 834
[2] Author Correction: CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome
Smita Kulkarni
Alexandra Lied
Viraj Kulkarni
Marijana Rucevic
Maureen P. Martin
Victoria Walker-Sperling
Stephen K. Anderson
Rodger Ewy
Sukhvinder Singh
Hoang Nguyen
Paul J. McLaren
Mathias Viard
Vivek Naranbhai
Chengcheng Zou
Zhansong Lin
Hiroyuki Gatanaga
Shinichi Oka
Masafumi Takiguchi
Chloe L. Thio
Joseph Margolick
Gregory D. Kirk
James J. Goedert
W. Keith Hoots
Steven G. Deeks
David W. Haas
Nelson Michael
Bruce Walker
Sylvie Le Gall
Fatema Z. Chowdhury
Xu G. Yu
Mary Carrington
Nature Immunology, 2019, 20 : 1555 - 1555
[3] CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome (vol 20, pg 824, 2019)
Kulkarni, Smita
Lied, Alexandra
Kulkarni, Viraj
Rucevic, Marijana
Martin, Maureen P.
Walker-Sperling, Victoria
Anderson, Stephen K.
Ewy, Rodger
Singh, Sukhvinder
Hoang Nguyen
McLaren, Paul J.
Viard, Mathias
Naranbhai, Vivek
Zou, Chengcheng
Lin, Zhansong
Gatanaga, Hiroyuki
Oka, Shinichi
Takiguchi, Masafumi
Thio, Chloe L.
Margolick, Joseph
Kirk, Gregory D.
Goedert, James J.
Hoots, W. Keith
Deeks, Steven G.
Haas, David W.
Michael, Nelson
Walker, Bruce
Le Gall, Sylvie
Chowdhury, Fatema Z.
Yu, Xu G.
Carrington, Mary
NATURE IMMUNOLOGY, 2019, 20 (11) : 1555 - 1555
[4] Variation of CCR5AS lncRNA Enhances HIV-1 Infection Through Regulation of CCR5 Expression
Zou, Sen
VIRAL IMMUNOLOGY, 2020, 33 (08) : 536 - 538
[5] CCR5 and HIV infection
Blanpain, C
Libert, F
Vassart, G
Parmentier, M
RECEPTORS & CHANNELS, 2002, 8 (01): : 19 - 31
[6] Genetic polymorphism of CCR5 gene and HIV disease:: the heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression
Morawetz, RA
Rizzardi, GP
Glauser, D
Rutschmann, O
Hirschel, B
Perrin, L
Opravil, M
Flepp, M
von Overbeck, J
Glauser, MP
Ghezzi, S
Vicenzi, E
Poli, G
Lazzarin, A
Pantaleo, G
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) : 3223 - 3227
[7] CCR5 and HIV: the less, the better
Roederer, Mario
Mattapallil, Joseph
BLOOD, 2007, 109 (03) : 854 - 854
[8] HIV CCR5 resistance incomplete
Smith, O
NATURE MEDICINE, 1997, 3 (04) : 372 - 373
[9] HIV CCR5 resistance incomplete
Orla Smith
Nature Medicine, 1997, 3 : 372 - 373
[10] The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection
Lehner, T
TRENDS IN IMMUNOLOGY, 2002, 23 (07) : 347 - 351

← 1 2 3 4 5 →